DAFSOLIMAB SETARITOX
UNII AG8ULI6K9U

Substance Identification & Data

This profile provides standardized clinical and technical data for Dafsolimab Setaritox, uniquely identified by the FDA Unique Ingredient Identifier (UNII) AG8ULI6K9U.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2361013-28-5 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
AG8ULI6K9U
CAS Registry Number
2361013-28-5
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
DAFSOLIMAB SETARITOX
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
National Cancer Institute reference terminology for clinical and research data.
INN ID
11489
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Dafsolimab Setaritox. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

DAFSOLIMAB SETARITOX

Common Names & Synonyms

DAFSOLIMAB SETARITOX [INN]
IMMUNOGLOBULIN G2A-LAMBDA, ANTI-(CD7 (CD7ANTIGEN (P41),GP40, LEU-9, TP41, TP40)), MUS MUSCULUS MONOCLONAL ANTIBODY CONJUGATED TO RICIN TOXIN A (RTA) (DAFSOLIMAB SETARITOX)
IMMUNOGLOBULIN G2B, ANTI-(HUMAN CD3 ANTIGEN .EPSILON..DELTA. COMPLEX) (MUS MUSCULUS MONOCLONAL SPV-T3A .GAMMA.2B-CHAIN), DISULFIDE WITH MUS MUSCULUS MONOCLONAL SPV-T3A .KAPPA.-CHAIN, DIMER, N6-(4-(1-MERCAPTOETHYL) BENZOYL) 260-DISULFIDE WITH RICIN A CHAIN (METHIONYL) (RECOMBINANT RICINUS COMMUNIS)